StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
TXRX4.SA$1.60+0.00%
Fair $1.60+0.0%

TXRX4.SA

Têxtil Renauxview S.A.

Consumer Cyclical / Textile ManufacturingSão Paulo

$1.60

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $1.60Fund rank 26/100 · Data gapFallback financials|
SA 21/D
F-Score: 2/9
Declining Revenue

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $13.8M · quality 44.0/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 15/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

21/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 3 consecutive years
Thesis & Journal · TXRX4.SALocal privado en este navegador · Têxtil Renauxview S.A.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$7M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

14.3%

↑

Gross Margin

21.2%

↓

Debt/Equity

-0.88

↓
52-Week Range$2
$2$2

TradingView lightweight chart

TXRX4.SA price, volumen y niveles de valoración

Último $1.600Periodo -76.8%
Fair value: $1.600

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-18.3%

FCF CAGR

—

FCF margin

-3.0%

FCF / Net income

0.06x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $115.9M · net income $-57.1M · FCF $-3.5M

2022-FY → 2025-FY

Gross margin

21.2%-9.4% pts

Operating margin

-17.5%-32.0% pts

Net margin

-49.3%-49.8% pts

FCF margin

-3.0%-1.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$115.9M$115.9M$117.7M$132.7M$212.4M
Net Income$-57.1M$-57.1M$-39.4M$16.7M$1.1M
EBITDA$-31.2M$-31.2M$-13.4M$34.0M$40.0M
EPS——-9.263.930.26
Gross Margin21.2%21.2%18.9%14.3%30.6%
Operating Margin-17.5%-17.5%-1.8%31.7%14.5%
Net Margin-49.3%-49.3%-33.5%12.6%0.5%
Balance Sheet
Debt/Equity-0.88-0.88-0.93-0.98-0.96
Current Ratio0.340.34———
Cash Flow
Free Cash Flow$-3.5M$-3.5M$13.8M$85.5M$-3.6M
Returns
ROE14.3%14.3%11.5%-5.3%-0.3%
Valuation
P/E———0.6913.65
EV/EBITDA———9.378.28
Growth & Yield
Revenue Growth-1.5%-1.5%-11.3%-37.5%—
EPS Growth——-335.6%1390.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -15.8%

Total return

-15.8%

Start / end P/E

n/dx → n/dx

EPS bridge

-9.26 → n/d

Residual

-15.8%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-15.8%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.